A patent and literature review of CDK12 inhibitors
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2022.2126765
Abstract: ABSTRACT Introduction Cyclin-dependent kinase 12 (CDK12) belongs to the CDK family of serine/threonine protein kinases and is associated with cyclin K to exert its biological functions, including regulating gene transcription, mRNA processing, and translation. Increasing… read more here.
Keywords: cdk12; patent literature; literature review; cdk12 inhibitors ... See more keywords